Literature DB >> 6611956

Apudomas metastatic to the liver: treatment by hepatic artery embolization.

C H Carrasco, V P Chuang, S Wallace.   

Abstract

Eighteen patients with various apudomas metastatic to the liver underwent hepatic artery embolization. In one group of 14 patients, hepatic artery embolization was the only antineoplastic therapy used during the study period. Three deaths occurred in this group. A partial remission of the hepatic metastases occurred in eight of the 11 living patients. In addition to hepatic artery embolization, a second group of four patients received concurrent hepatic artery infusions of chemotherapeutic agents. A partial remission occurred in three of these patients. Hepatic artery embolization may offer significant palliation for patients with apudomas metastatic to the liver by reducing the tumor bulk and thus decreasing the production of pharmacologically active substances secreted by functioning tumors. The impact of this treatment on the median survival time of patients with apudomas could not be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6611956     DOI: 10.1148/radiology.149.1.6611956

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  12 in total

Review 1.  Clinical pathways for pancreatic neuroendocrine tumors.

Authors:  Angela Alistar; Max Sung; Michelle Kim; Randall F Holcombe
Journal:  J Gastrointest Cancer       Date:  2012-12

2.  Vasoactive intestinal polypeptide-secreting tumor (VIPoma) with liver metastases: dramatic and durable symptomatic benefit from hepatic artery embolization, a case report.

Authors:  C C Case; K Wirfel; R Vassilopoulou-Sellin
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

3.  ACTH-producing apudoma metastatic to the liver.

Authors:  S I Long
Journal:  J Natl Med Assoc       Date:  1987-01       Impact factor: 1.798

4.  Minute liver metastases from a rectal carcinoid: A case report and review.

Authors:  Hirofumi Yamamoto; Hideyuki Hemmi; Jin-Yu Gu; Mitsugu Sekimoto; Yuichiro Doki; Masaki Mori
Journal:  World J Gastrointest Surg       Date:  2010-03-27

5.  Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogs.

Authors:  M L Fjällskog; A Sundin; J E Westlin; K Oberg; E T Janson; B Eriksson
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

Review 6.  Intra-arterial liver-directed therapies for neuroendocrine hepatic metastases.

Authors:  Sanjay Gupta
Journal:  Semin Intervent Radiol       Date:  2013-03       Impact factor: 1.513

Review 7.  Optimal treatment of Zollinger-Ellison syndrome and related conditions in elderly patients.

Authors:  Paola Tomassetti; Teresa Salomone; Marina Migliori; Davide Campana; Roberto Corinaldesi
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

Review 8.  [Drug therapy of endocrine neoplasms. Part II: Malignant gastrinomas, insulinomas, glucagonomas, carcinoids and other tumors].

Authors:  M Schott; W A Scherbaum; J Feldkamp
Journal:  Med Klin (Munich)       Date:  2000-02-15

9.  Malignant insulinoma: permanent hepatic artery embolization of liver metastases--preliminary results.

Authors:  F W Winkelbauer; B Nierderle; O Graf; R Prokesch; S Thurnher; R Wildling; J Lammer
Journal:  Cardiovasc Intervent Radiol       Date:  1995 Nov-Dec       Impact factor: 2.740

Review 10.  Current diagnosis and management of Zollinger-Ellison syndrome.

Authors:  D K Andersen
Journal:  Ann Surg       Date:  1989-12       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.